Kim A. Selting, DVM, MS, DACVIM (oncology)

Veterinary oncologist Dr. Kim Selting provides her advice on achieving the best outcomes in these cases.

Dr. Kimberly Selting discusses the many benefits of clinical trials.

A general review of lymphoma then discuss various novel therapies currently available for the palliation and control of this cancer in dogs.

Clinical trials are an important part of our profession.

A standard and reliable approach to the diagnosis of a cancer case typically will lead the experienced veterinarian to an answer.

Each year, thousands of compounds are screened for possible anticancer properties.

Primary lung cancer is uncommon in dogs, comprising around 1% of all cancer in this species.

Dogs and cats with cancer are typically presented by their owners either because of the physical presence of the mass if it is visible or palpable, or because of the effect of the cancer on the body and its functions.

Cancer chemotherapy is a relatively recent development in medical history.

Mast cell tumors (MCT) are among the most common tumors treated in dogs and are periodically seen in cats.

A general review of osteosarcoma then discuss various novel therapies currently available for the local and systemic treatment of this cancer in dogs.